Retatrutide, a novel dual stimulator of the GLP-1 receptor and glucose-dependent released polypeptide (GIP) receptor , is exhibiting promising results in initial patient studies. Ongoing research https://hubwebsites.com/story22855258/retatrutide-emerging-research-and-projected-therapeutic-uses